amwl-10q_20210930.htm
false
Q3
0001393584
--12-31
true
true
true
true
true
true
true
0.113
P5Y
P5Y
P7Y
P5Y
P10Y
P10Y
P8Y7M6D
P7Y3M18D
P6Y3M18D
P5Y6M
P7Y
P8Y
P0Y
P7Y6M
P6Y2M12D
P6Y
P6Y
P5Y10M24D
P5Y6M
P5Y7M6D
P0Y
P6Y1M6D
0001393584
2021-01-01
2021-09-30
xbrli:shares
0001393584
us-gaap:CommonClassAMember
2021-10-31
0001393584
us-gaap:CommonClassBMember
2021-10-31
0001393584
us-gaap:CommonClassCMember
2021-10-31
iso4217:USD
0001393584
2021-09-30
0001393584
2020-12-31
iso4217:USD
xbrli:shares
0001393584
us-gaap:CommonClassAMember
2021-09-30
0001393584
us-gaap:CommonClassAMember
2020-12-31
0001393584
us-gaap:CommonClassBMember
2021-09-30
0001393584
us-gaap:CommonClassBMember
2020-12-31
0001393584
us-gaap:CommonClassCMember
2021-09-30
0001393584
us-gaap:CommonClassCMember
2020-12-31
0001393584
2021-07-01
2021-09-30
0001393584
2020-07-01
2020-09-30
0001393584
2020-01-01
2020-09-30
0001393584
us-gaap:CommonStockMember
2020-12-31
0001393584
us-gaap:TreasuryStockMember
2020-12-31
0001393584
us-gaap:AdditionalPaidInCapitalMember
2020-12-31
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-12-31
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2020-12-31
0001393584
us-gaap:ParentMember
2020-12-31
0001393584
us-gaap:NoncontrollingInterestMember
2020-12-31
0001393584
us-gaap:CommonStockMember
2021-01-01
2021-03-31
0001393584
us-gaap:AdditionalPaidInCapitalMember
2021-01-01
2021-03-31
0001393584
us-gaap:ParentMember
2021-01-01
2021-03-31
0001393584
2021-01-01
2021-03-31
0001393584
us-gaap:TreasuryStockMember
2021-01-01
2021-03-31
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2021-01-01
2021-03-31
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-01-01
2021-03-31
0001393584
us-gaap:NoncontrollingInterestMember
2021-01-01
2021-03-31
0001393584
us-gaap:CommonStockMember
2021-03-31
0001393584
us-gaap:AdditionalPaidInCapitalMember
2021-03-31
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-03-31
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2021-03-31
0001393584
us-gaap:ParentMember
2021-03-31
0001393584
us-gaap:NoncontrollingInterestMember
2021-03-31
0001393584
2021-03-31
0001393584
us-gaap:CommonStockMember
2021-04-01
2021-06-30
0001393584
us-gaap:AdditionalPaidInCapitalMember
2021-04-01
2021-06-30
0001393584
us-gaap:ParentMember
2021-04-01
2021-06-30
0001393584
2021-04-01
2021-06-30
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2021-04-01
2021-06-30
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-04-01
2021-06-30
0001393584
us-gaap:NoncontrollingInterestMember
2021-04-01
2021-06-30
0001393584
us-gaap:CommonStockMember
2021-06-30
0001393584
us-gaap:AdditionalPaidInCapitalMember
2021-06-30
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-06-30
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2021-06-30
0001393584
us-gaap:ParentMember
2021-06-30
0001393584
us-gaap:NoncontrollingInterestMember
2021-06-30
0001393584
2021-06-30
0001393584
us-gaap:CommonStockMember
2021-07-01
2021-09-30
0001393584
us-gaap:AdditionalPaidInCapitalMember
2021-07-01
2021-09-30
0001393584
us-gaap:ParentMember
2021-07-01
2021-09-30
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2021-07-01
2021-09-30
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-07-01
2021-09-30
0001393584
us-gaap:NoncontrollingInterestMember
2021-07-01
2021-09-30
0001393584
us-gaap:CommonStockMember
2021-09-30
0001393584
us-gaap:AdditionalPaidInCapitalMember
2021-09-30
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-09-30
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2021-09-30
0001393584
us-gaap:ParentMember
2021-09-30
0001393584
us-gaap:NoncontrollingInterestMember
2021-09-30
0001393584
us-gaap:ConvertiblePreferredStockMember
2019-12-31
0001393584
us-gaap:CommonStockMember
2019-12-31
0001393584
us-gaap:TreasuryStockMember
2019-12-31
0001393584
us-gaap:AdditionalPaidInCapitalMember
2019-12-31
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-12-31
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2019-12-31
0001393584
us-gaap:ParentMember
2019-12-31
0001393584
us-gaap:NoncontrollingInterestMember
2019-12-31
0001393584
2019-12-31
0001393584
us-gaap:ConvertiblePreferredStockMember
2020-01-01
2020-03-31
0001393584
us-gaap:CommonStockMember
2020-01-01
2020-03-31
0001393584
us-gaap:AdditionalPaidInCapitalMember
2020-01-01
2020-03-31
0001393584
us-gaap:ParentMember
2020-01-01
2020-03-31
0001393584
2020-01-01
2020-03-31
0001393584
us-gaap:TreasuryStockMember
2020-01-01
2020-03-31
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-01-01
2020-03-31
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2020-01-01
2020-03-31
0001393584
us-gaap:NoncontrollingInterestMember
2020-01-01
2020-03-31
0001393584
us-gaap:ConvertiblePreferredStockMember
2020-03-31
0001393584
us-gaap:CommonStockMember
2020-03-31
0001393584
us-gaap:AdditionalPaidInCapitalMember
2020-03-31
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-03-31
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2020-03-31
0001393584
us-gaap:ParentMember
2020-03-31
0001393584
us-gaap:NoncontrollingInterestMember
2020-03-31
0001393584
2020-03-31
0001393584
us-gaap:ConvertiblePreferredStockMember
2020-04-01
2020-06-30
0001393584
us-gaap:CommonStockMember
2020-04-01
2020-06-30
0001393584
us-gaap:TreasuryStockMember
2020-04-01
2020-06-30
0001393584
us-gaap:ParentMember
2020-04-01
2020-06-30
0001393584
2020-04-01
2020-06-30
0001393584
us-gaap:AdditionalPaidInCapitalMember
2020-04-01
2020-06-30
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-04-01
2020-06-30
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2020-04-01
2020-06-30
0001393584
us-gaap:NoncontrollingInterestMember
2020-04-01
2020-06-30
0001393584
us-gaap:ConvertiblePreferredStockMember
2020-06-30
0001393584
us-gaap:CommonStockMember
2020-06-30
0001393584
us-gaap:TreasuryStockMember
2020-06-30
0001393584
us-gaap:AdditionalPaidInCapitalMember
2020-06-30
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-06-30
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2020-06-30
0001393584
us-gaap:ParentMember
2020-06-30
0001393584
us-gaap:NoncontrollingInterestMember
2020-06-30
0001393584
2020-06-30
0001393584
us-gaap:CommonStockMember
2020-07-01
2020-09-30
0001393584
us-gaap:AdditionalPaidInCapitalMember
2020-07-01
2020-09-30
0001393584
us-gaap:ParentMember
2020-07-01
2020-09-30
0001393584
us-gaap:TreasuryStockMember
2020-07-01
2020-09-30
0001393584
us-gaap:ConvertiblePreferredStockMember
2020-07-01
2020-09-30
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-07-01
2020-09-30
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2020-07-01
2020-09-30
0001393584
us-gaap:NoncontrollingInterestMember
2020-07-01
2020-09-30
0001393584
us-gaap:CommonStockMember
2020-09-30
0001393584
us-gaap:TreasuryStockMember
2020-09-30
0001393584
us-gaap:AdditionalPaidInCapitalMember
2020-09-30
0001393584
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-09-30
0001393584
us-gaap:RetainedEarningsAppropriatedMember
2020-09-30
0001393584
us-gaap:ParentMember
2020-09-30
0001393584
us-gaap:NoncontrollingInterestMember
2020-09-30
0001393584
2020-09-30
0001393584
us-gaap:SeriesCPreferredStockMember
2020-01-01
2020-03-31
0001393584
us-gaap:SeriesCPreferredStockMember
2020-04-01
2020-06-30
0001393584
us-gaap:CommonClassAMember
2020-07-01
2020-09-30
0001393584
us-gaap:CommonClassAMember
us-gaap:PrivatePlacementMember
2020-07-01
2020-09-30
0001393584
amwl:ConversaHealthIncMember
2021-08-09
2021-08-09
0001393584
amwl:SilverCloudHealthHoldingsIncMember
2021-08-27
2021-08-27
0001393584
us-gaap:IPOMember
2020-09-21
2020-09-21
0001393584
2020-09-21
2020-09-21
xbrli:pure
0001393584
srt:MaximumMember
2021-01-01
2021-09-30
amwl:Segment
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2021-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2020-12-31
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2021-07-01
2021-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2020-07-01
2020-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2021-01-01
2021-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2020-01-01
2020-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
amwl:CcacvJvLlcMember
2020-01-01
2020-12-31
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
amwl:CcacvJvLlcMember
2020-12-31
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
amwl:CcacvJvLlcMember
2021-01-01
2021-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
amwl:CcacvJvLlcMember
2021-07-01
2021-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
amwl:CcacvJvLlcMember
2020-07-01
2020-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
amwl:CcacvJvLlcMember
2020-01-01
2020-09-30
0001393584
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
amwl:CcacvJvLlcMember
2021-09-30
0001393584
us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember
amwl:RelatedPartyCustomerOneMember
2021-01-01
2021-09-30
0001393584
us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember
amwl:RelatedPartyCustomerOneMember
2020-01-01
2020-12-31
0001393584
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
amwl:RelatedPartyCustomerOneMember
2021-07-01
2021-09-30
0001393584
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
amwl:RelatedPartyCustomerOneMember
2020-07-01
2020-09-30
0001393584
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
amwl:RelatedPartyCustomerOneMember
2021-01-01
2021-09-30
0001393584
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
amwl:RelatedPartyCustomerOneMember
2020-01-01
2020-09-30
0001393584
us-gaap:AccountingStandardsUpdate201813Member
2021-09-30
0001393584
us-gaap:AccountingStandardsUpdate201815Member
2021-09-30
0001393584
us-gaap:AccountingStandardsUpdate201912Member
2021-09-30
0001393584
amwl:AccountingStandardsUpdate202108Member
2021-09-30
0001393584
amwl:PlatformSubscriptionMember
2021-07-01
2021-09-30
0001393584
amwl:PlatformSubscriptionMember
2020-07-01
2020-09-30
0001393584
amwl:PlatformSubscriptionMember
2021-01-01
2021-09-30
0001393584
amwl:PlatformSubscriptionMember
2020-01-01
2020-09-30
0001393584
amwl:VisitsMember
2021-07-01
2021-09-30
0001393584
amwl:VisitsMember
2020-07-01
2020-09-30
0001393584
amwl:VisitsMember
2021-01-01
2021-09-30
0001393584
amwl:VisitsMember
2020-01-01
2020-09-30
0001393584
amwl:OthersMember
2021-07-01
2021-09-30
0001393584
amwl:OthersMember
2020-07-01
2020-09-30
0001393584
amwl:OthersMember
2021-01-01
2021-09-30
0001393584
amwl:OthersMember
2020-01-01
2020-09-30
0001393584
2020-01-01
2020-12-31
0001393584
us-gaap:UnbilledRevenuesMember
2021-09-30
0001393584
us-gaap:UnbilledRevenuesMember
2020-12-31
0001393584
2021-10-01
2021-09-30
0001393584
2021-01-01
2020-12-31
0001393584
srt:MinimumMember
amwl:NtnMemberMember
2016-01-01
0001393584
srt:MaximumMember
amwl:NtnMemberMember
2016-01-01
0001393584
amwl:NtnMemberMember
2021-07-01
2021-09-30
0001393584
amwl:NtnMemberMember
2020-07-01
2020-09-30
0001393584
amwl:NtnMemberMember
2021-01-01
2021-09-30
0001393584
amwl:NtnMemberMember
2020-01-01
2020-09-30
0001393584
us-gaap:NoncontrollingInterestMember
amwl:NtnMemberMember
2021-09-30
0001393584
us-gaap:NoncontrollingInterestMember
amwl:NtnMemberMember
2020-12-31
0001393584
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2021-09-30
0001393584
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
2021-09-30
0001393584
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2021-09-30
0001393584
us-gaap:FairValueMeasurementsRecurringMember
2021-09-30
0001393584
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
amwl:ContingentConsiderationMember
2021-09-30
0001393584
us-gaap:FairValueMeasurementsRecurringMember
amwl:ContingentConsiderationMember
2021-09-30
0001393584
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-09-30
0001393584
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MoneyMarketFundsMember
2020-12-31
0001393584
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MoneyMarketFundsMember
2020-12-31
0001393584
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InvestmentsMember
2020-12-31
0001393584
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InvestmentsMember
2020-12-31
0001393584
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2020-12-31
0001393584
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2020-12-31
0001393584
us-gaap:FairValueMeasurementsRecurringMember
2020-12-31
0001393584
amwl:SilverCloudHealthHoldingsIncMember
2021-01-01
2021-09-30
0001393584
amwl:ConversaHealthIncMember
2021-01-01
2021-09-30
0001393584
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2020-12-31
0001393584
amwl:SilverCloudHealthHoldingsIncMember
us-gaap:CommonClassAMember
2021-08-27
2021-08-27
0001393584
amwl:SilverCloudHealthHoldingsIncMember
2021-08-27
0001393584
amwl:ConversaHealthIncMember
us-gaap:CommonClassAMember
2021-08-09
2021-08-09
0001393584
amwl:ConversaHealthIncMember
2021-08-09
0001393584
amwl:SilverCloudHealthHoldingsIncMember
us-gaap:TechnologyBasedIntangibleAssetsMember
2021-08-27
2021-08-27
0001393584
amwl:SilverCloudHealthHoldingsIncMember
us-gaap:TradeNamesMember
2021-08-27
2021-08-27
0001393584
amwl:SilverCloudHealthHoldingsIncMember
us-gaap:CustomerRelationshipsMember
2021-08-27
2021-08-27
0001393584
amwl:ConversaHealthIncMember
us-gaap:TechnologyBasedIntangibleAssetsMember
2021-08-09
2021-08-09
0001393584
amwl:ConversaHealthIncMember
us-gaap:TradeNamesMember
2021-08-09
2021-08-09
0001393584
amwl:ConversaHealthIncMember
us-gaap:CustomerRelationshipsMember
2021-08-09
2021-08-09
0001393584
us-gaap:CustomerRelationshipsMember
2021-09-30
0001393584
us-gaap:ContractBasedIntangibleAssetsMember
2021-09-30
0001393584
us-gaap:TradeNamesMember
2021-09-30
0001393584
us-gaap:TechnologyBasedIntangibleAssetsMember
2021-09-30
0001393584
us-gaap:CustomerRelationshipsMember
2020-12-31
0001393584
us-gaap:ContractBasedIntangibleAssetsMember
2020-12-31
0001393584
us-gaap:TradeNamesMember
2020-12-31
0001393584
us-gaap:TechnologyBasedIntangibleAssetsMember
2020-12-31
0001393584
us-gaap:CustomerRelationshipsMember
2021-01-01
2021-09-30
0001393584
us-gaap:ContractBasedIntangibleAssetsMember
2021-01-01
2021-09-30
0001393584
us-gaap:TradeNamesMember
2021-01-01
2021-09-30
0001393584
us-gaap:TechnologyBasedIntangibleAssetsMember
2021-01-01
2021-09-30
0001393584
us-gaap:CustomerRelationshipsMember
2020-01-01
2020-12-31
0001393584
us-gaap:ContractBasedIntangibleAssetsMember
2020-01-01
2020-12-31
0001393584
us-gaap:TradeNamesMember
2020-01-01
2020-12-31
0001393584
us-gaap:TechnologyBasedIntangibleAssetsMember
2020-01-01
2020-12-31
0001393584
amwl:TwoThousandAndElevenLineOfCreditFacilityMember
2011-01-31
0001393584
us-gaap:LondonInterbankOfferedRateLIBORMember
amwl:TwoThousandAndElevenLineOfCreditFacilityMember
2011-01-30
2011-01-31
0001393584
amwl:TwoThousandAndSeventeenAmendedLineOfCreditFacilityMember
2017-11-30
0001393584
amwl:TwoThousandAndSeventeenAmendedLineOfCreditFacilityMember
2021-09-30
0001393584
amwl:TwoThousandAndSeventeenAmendedLineOfCreditFacilityMember
2020-12-31
0001393584
amwl:RedeemableConvertiblePreferredStockSeriesAMember
2019-12-31
0001393584
amwl:RedeemableConvertiblePreferredStockSeriesBMember
2019-12-31
0001393584
amwl:RedeemableConvertiblePreferredStockSeriesCMember
2019-12-31
0001393584
us-gaap:SeriesCPreferredStockMember
2020-02-01
2020-02-29
0001393584
us-gaap:SeriesCPreferredStockMember
2020-02-29
0001393584
us-gaap:SeriesCPreferredStockMember
2020-05-01
2020-05-31
0001393584
us-gaap:SeriesCPreferredStockMember
2020-05-31
0001393584
us-gaap:ConvertiblePreferredStockMember
2020-09-30
0001393584
us-gaap:ConvertiblePreferredStockMember
2021-01-01
2021-09-30
0001393584
us-gaap:ConvertiblePreferredStockMember
2020-09-01
2020-09-30
0001393584
us-gaap:PreferredStockMember
2020-09-30
0001393584
us-gaap:CommonClassAMember
2020-09-01
2020-09-30
0001393584
us-gaap:CommonClassAMember
2020-09-30
0001393584
us-gaap:CommonClassCMember
2020-09-01
2020-09-30
0001393584
us-gaap:IPOMember
2020-09-01
2020-09-30
0001393584
us-gaap:IPOMember
amwl:CommonStockClassAAndClassBMember
2020-09-01
2020-09-30
0001393584
us-gaap:CommonClassBMember
2020-09-30
0001393584
us-gaap:CommonClassCMember
2020-09-30
0001393584
us-gaap:CommonClassAMember
2021-01-01
2021-09-30
0001393584
us-gaap:CommonClassBMember
2021-01-01
2021-09-30
0001393584
us-gaap:CommonClassCMember
2021-01-01
2021-09-30
0001393584
amwl:TwoThousandAndTwentyEquityIncentivePlanMember
2020-12-31
0001393584
amwl:TwoThousandAndTwentyEquityIncentivePlanMember
2021-01-01
2021-09-30
0001393584
amwl:TwoThousandAndTwentyEquityIncentivePlanMember
2021-09-30
0001393584
amwl:TwoThousandAndTwentyEquityIncentivePlanMember
2020-01-01
2020-12-31
0001393584
amwl:TwoThousandAndTwentyEquityIncentivePlanMember
2020-01-01
2020-09-30
0001393584
srt:ChiefExecutiveOfficerMember
us-gaap:RestrictedStockMember
amwl:ExecutiveEquityAwardsMember
2021-01-01
2021-09-30
0001393584
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
us-gaap:RestrictedStockMember
amwl:ExecutiveEquityAwardsMember
2021-01-01
2021-09-30
0001393584
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
us-gaap:RestrictedStockMember
amwl:ExecutiveEquityAwardsMember
2020-09-01
2020-09-30
0001393584
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
us-gaap:RestrictedStockMember
amwl:ExecutiveEquityAwardsMember
2021-01-01
2021-09-30
0001393584
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
us-gaap:RestrictedStockMember
amwl:ExecutiveEquityAwardsMember
2020-09-01
2020-09-30
0001393584
us-gaap:RestrictedStockMember
srt:ChiefExecutiveOfficerMember
amwl:ExecutiveEquityAwardsMember
2021-09-30
0001393584
amwl:ExecutiveEquityAwardsMember
2021-01-01
2021-09-30
0001393584
us-gaap:RestrictedStockMember
2020-01-01
2020-12-31
0001393584
us-gaap:RestrictedStockMember
2021-01-01
2021-09-30
0001393584
us-gaap:RestrictedStockMember
srt:MinimumMember
2020-01-01
2020-12-31
0001393584
us-gaap:RestrictedStockMember
srt:MaximumMember
2020-01-01
2020-12-31
0001393584
us-gaap:RestrictedStockMember
srt:MinimumMember
2021-01-01
2021-09-30
0001393584
us-gaap:RestrictedStockMember
srt:MaximumMember
2021-01-01
2021-09-30
0001393584
us-gaap:RestrictedStockUnitsRSUMember
2020-12-31
0001393584
us-gaap:RestrictedStockUnitsRSUMember
2021-01-01
2021-09-30
0001393584
us-gaap:RestrictedStockUnitsRSUMember
2021-09-30
0001393584
us-gaap:RestrictedStockMember
2020-01-01
2020-09-30
0001393584
amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember
2020-08-31
0001393584
amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember
2021-01-01
2021-09-30
0001393584
amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember
2021-07-01
2021-09-30
0001393584
amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember
2021-09-30
0001393584
amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember
2020-01-01
2020-09-30
0001393584
amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember
2020-07-01
2020-09-30
0001393584
us-gaap:CostOfSalesMember
2021-07-01
2021-09-30
0001393584
us-gaap:CostOfSalesMember
2020-07-01
2020-09-30
0001393584
us-gaap:CostOfSalesMember
2021-01-01
2021-09-30
0001393584
us-gaap:CostOfSalesMember
2020-01-01
2020-09-30
0001393584
us-gaap:ResearchAndDevelopmentExpenseMember
2021-07-01
2021-09-30
0001393584
us-gaap:ResearchAndDevelopmentExpenseMember
2020-07-01
2020-09-30
0001393584
us-gaap:ResearchAndDevelopmentExpenseMember
2021-01-01
2021-09-30
0001393584
us-gaap:ResearchAndDevelopmentExpenseMember
2020-01-01
2020-09-30
0001393584
us-gaap:SellingAndMarketingExpenseMember
2021-07-01
2021-09-30
0001393584
us-gaap:SellingAndMarketingExpenseMember
2020-07-01
2020-09-30
0001393584
us-gaap:SellingAndMarketingExpenseMember
2021-01-01
2021-09-30
0001393584
us-gaap:SellingAndMarketingExpenseMember
2020-01-01
2020-09-30
0001393584
us-gaap:GeneralAndAdministrativeExpenseMember
2021-07-01
2021-09-30
0001393584
us-gaap:GeneralAndAdministrativeExpenseMember
2020-07-01
2020-09-30
0001393584
us-gaap:GeneralAndAdministrativeExpenseMember
2021-01-01
2021-09-30
0001393584
us-gaap:GeneralAndAdministrativeExpenseMember
2020-01-01
2020-09-30
0001393584
us-gaap:CommonStockMember
amwl:EquityAwardPlanMember
2021-09-30
0001393584
us-gaap:CommonStockMember
amwl:EquityAwardPlanMember
2021-01-01
2021-09-30
0001393584
us-gaap:IndemnificationGuaranteeMember
2021-01-01
2021-09-30
0001393584
us-gaap:IndemnificationGuaranteeMember
2020-01-01
2020-12-31
0001393584
us-gaap:PendingLitigationMember
2021-09-30
0001393584
us-gaap:PendingLitigationMember
2020-12-31
0001393584
amwl:NewLeaseMember
2021-09-30
0001393584
amwl:TevaPharmaceuticalsIndustriesLtdMember
2020-12-31
0001393584
amwl:TevaPharmaceuticalsIndustriesLtdMember
2020-07-01
2020-09-30
0001393584
amwl:TevaPharmaceuticalsIndustriesLtdMember
2020-01-01
2020-09-30
0001393584
amwl:PhilipsHoldingUsaIncMember
2020-12-31
0001393584
amwl:PhilipsHoldingUsaIncMember
2021-06-01
2021-06-30
0001393584
amwl:PhilipsHoldingUsaIncMember
2020-07-01
2020-09-30
0001393584
amwl:PhilipsHoldingUsaIncMember
2020-01-01
2020-09-30
0001393584
amwl:AnthemIncMember
2020-12-31
0001393584
amwl:AnthemIncMember
2020-07-01
2020-09-30
0001393584
amwl:AnthemIncMember
2020-01-01
2020-09-30
0001393584
amwl:ClevelandClinicMember
2021-09-30
0001393584
amwl:ClevelandClinicMember
2020-12-31
0001393584
amwl:ClevelandClinicMember
2021-07-01
2021-09-30
0001393584
amwl:ClevelandClinicMember
2020-07-01
2020-09-30
0001393584
amwl:ClevelandClinicMember
2021-01-01
2021-09-30
0001393584
amwl:ClevelandClinicMember
2020-01-01
2020-09-30
0001393584
amwl:CcawJvLlcMember
2020-01-01
2020-12-31
0001393584
amwl:CcawJvLlcMember
2021-01-01
2021-09-30
0001393584
amwl:CcawJvLlcMember
2020-12-31
0001393584
amwl:CcawJvLlcMember
2021-07-01
2021-09-30
0001393584
amwl:CcawJvLlcMember
2020-07-01
2020-09-30
0001393584
amwl:CcawJvLlcMember
2020-01-01
2020-09-30
0001393584
amwl:CcawJvLlcMember
2021-09-30
0001393584
amwl:UnvestedRestrictedStockMember
2021-07-01
2021-09-30
0001393584
amwl:UnvestedRestrictedStockMember
2020-07-01
2020-09-30
0001393584
amwl:UnvestedRestrictedStockMember
2021-01-01
2021-09-30
0001393584
amwl:UnvestedRestrictedStockMember
2020-01-01
2020-09-30
0001393584
us-gaap:EmployeeStockOptionMember
2021-07-01
2021-09-30
0001393584
us-gaap:EmployeeStockOptionMember
2020-07-01
2020-09-30
0001393584
us-gaap:EmployeeStockOptionMember
2021-01-01
2021-09-30
0001393584
us-gaap:EmployeeStockOptionMember
2020-01-01
2020-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2021
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-39515
American Well Corporation
(Exact name of registrant as specified in its charter)
Delaware |
20-5009396 |
(State of incorporation) |
(I.R.S. Employer Identification Number) |
75 State Street, 26th Floor
Boston, MA 02109
(Address of registrant’s principal executive offices)
(617) 204-3500
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☐ |
|
Accelerated filer |
☐ |
|
|
|
|
|
Non-accelerated filer |
☒ |
|
Smaller reporting company |
☐ |
|
|
|
|
|
|
|
|
Emerging growth company |
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Class A common stock, par value of $0.01 per share |
|
AMWL |
|
The New York Stock Exchange |
As of October 31, 2021, the number of shares of the registrant’s Class A common stock outstanding was 227,489,928, the number of shares of the registrant’s Class B common stock outstanding was 26,913,579 and the number of shares of the registrant’s Class C common stock outstanding was 5,555,555.
American Well Corporation
QUARTERLY REPORT ON FORM 10-Q
For the period ended September 30, 2021
TABLE OF CONTENTS
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
AMERICAN WELL CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
(unaudited)
|
|
September 30, 2021 |
|
|
December 31, 2020 |
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
790,402 |
|
|
$ |
941,616 |
|
Investments |
|
|
— |
|
|
|
99,963 |
|
Restricted cash |
|
|
— |
|
|
|
1,095 |
|
Accounts receivable ($497 and $12,053, from related parties and net of
allowances of $1,497 and $1,556, respectively) |
|
|
39,851 |
|
|
|
45,296 |
|
Inventories |
|
|
9,100 |
|
|
|
9,128 |
|
Deferred contract acquisition costs |
|
|
1,339 |
|
|
|
2,134 |
|
Prepaid expenses and other current assets |
|
|
13,902 |
|
|
|
14,055 |
|
Total current assets |
|
|
854,594 |
|
|
|
1,113,287 |
|
Restricted cash |
|
|
795 |
|
|
|
— |
|
Property and equipment, net |
|
|
2,714 |
|
|
|
3,836 |
|
Goodwill |
|
|
443,903 |
|
|
|
193,877 |
|
Intangible assets, net |
|
|
159,926 |
|
|
|
55,528 |
|
Operating lease right-of-use asset |
|
|
17,780 |
|
|
|
6,609 |
|
Deferred contract acquisition costs, net of current portion |
|
|
1,921 |
|
|
|
1,327 |
|
Other assets |
|
|
1,520 |
|
|
|
1,430 |
|
Investment in minority owned joint venture |
|
|
1,205 |
|
|
|
752 |
|
Total assets |
|
$ |
1,484,358 |
|
|
$ |
1,376,646 |
|
Liabilities, Convertible Preferred Stock and Stockholders’ Deficit |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
5,278 |
|
|
$ |
5,797 |
|
Accrued expenses and other current liabilities |
|
|
45,910 |
|
|
|
42,135 |
|
Contingent consideration liabilities |
|
|
11,850 |
|
|
|
— |
|
Operating lease liability, current |
|
|
3,121 |
|
|
|
6,357 |
|
Deferred revenue ($683 and $14,421 from related parties, respectively) |
|
|
60,949 |
|
|
|
66,693 |
|
Total current liabilities |
|
|
127,108 |
|
|
|
120,982 |
|
Other long-term liabilities |
|
|
4,210 |
|
|
|
64 |
|
Contingent consideration liabilities, net of current portion |
|
|
33,340 |
|
|
|
|
|
Operating lease liability, net of current portion |
|
|
14,988 |
|
|
|
1,296 |
|
Deferred revenue, net of current portion ($26 and $486 from related
parties, respectively) |
|
|
7,050 |
|
|
|
8,107 |
|
Total liabilities |
|
|
186,696 |
|
|
|
130,449 |
|
Commitments and contingencies (Note 12) |
|
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Preferred stock, $0.01 par value; 100,000,000 shares authorized, no shares
issued or outstanding as of September 30, 2021 and as of December 31, 2020 |
|
|
— |
|
|
|
— |
|
Common stock, $0.01 par value; 1,000,000,000 Class A shares authorized, 227,158,943 and
201,488,097 shares issued, and 227,158,943 and 200,751,168 shares outstanding, respectively;
100,000,000 Class B shares authorized, 26,650,761 and 30,427,128 shares issued, and 26,650,761
and 29,297,382 shares outstanding, respectively; 200,000,000 Class C shares authorized 5,555,555
issued and outstanding as of September 30, 2021 and December 31, 2020 |
|
|
2,595 |
|
|
|
2,357 |
|
Treasury stock, no shares and 1,866,675 shares as of September 30, 2021
and December 31, 2020, respectively |
|
|
— |
|
|
|
(37,568 |
) |
Additional paid-in capital |
|
|
2,038,012 |
|
|
|
1,841,405 |
|
Accumulated other comprehensive income |
|
|
(2,237 |
) |
|
|
297 |
|
Accumulated deficit |
|
|
(762,441 |
) |
|
|
(582,359 |
) |
Total American Well Corporation stockholders’ equity |
|
|
1,275,929 |
|
|
|
1,224,132 |
|
Non-controlling interest |
|
|
21,733 |
|
|
|
22,065 |
|
Total stockholders’ equity |
|
|
1,297,662 |
|
|
|
1,246,197 |
|
Total liabilities and stockholders’ equity |
|
$ |
1,484,358 |
|
|
$ |
1,376,646 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
AMERICAN WELL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except share and per share amounts)
(unaudited)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($698, $15,912, $11,005 and $29,160 from related parties, respectively) |
|
$ |
62,223 |
|
|
$ |
62,551 |
|
|
$ |
180,039 |
|
|
$ |
184,833 |
|
|
Costs and operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs of revenue, excluding depreciation and amortization of intangible assets |
|
|
35,184 |
|
|
|
42,116 |
|
|
|
104,778 |
|
|
|
118,969 |
|
Research and development |
|
|
27,399 |
|
|
|
25,275 |
|
|
|
72,817 |
|
|
|
57,848 |
|
Sales and marketing |
|
|
16,370 |
|
|
|
13,758 |
|
|
|
44,891 |
|
|
|
39,978 |
|
General and administrative |
|
|
34,380 |
|
|
|
43,113 |
|
|
|
79,946 |
|
|
|
138,537 |
|
Depreciation and amortization expense |
|
|
4,340 |
|
|
|
2,576 |
|
|
|
9,330 |
|
|
|
7,371 |
|
Total costs and operating expenses |
|
|
117,673 |
|
|
|
126,838 |
|
|
|
311,762 |
|
|
|
362,703 |
|
Loss from operations |
|
|
(55,450 |
) |
|
|
(64,287 |
) |
|
|
(131,723 |
) |
|
|
(177,870 |
) |
Interest income and other (expense) income, net |
|
|
(382 |
) |
|
|
255 |
|
|
|
(97 |
) |
|
|
1,410 |
|
Loss before expense from income taxes and loss from
equity method investment |
|
|
(55,832 |
) |
|
|
(64,032 |
) |
|
|
(131,820 |
) |
|
|
(176,460 |
) |
Benefit (Expense) from income taxes |
|
|
5,454 |
|
|
|
(78 |
) |
|
|
5,042 |
|
|
|
(330 |
) |
Loss from equity method investment |
|
|
(554 |
) |
|
|
(486 |
) |
|
|
(2,095 |
) |
|
|
(1,250 |
) |
Net loss |
|
|
(50,932 |
) |
|
|
(64,596 |
) |
|
|
(128,873 |
) |
|
|
(178,040 |
) |
Net income (loss) attributable to non-controlling interest |
|
|
562 |
|
|
|
(1,515 |
) |
|
|
(332 |
) |
|
|
(3,920 |
) |
Net loss attributable to American Well Corporation |
|
$ |
(51,494 |
) |
|
$ |
(63,081 |
) |
|
$ |
(128,541 |
) |
|
$ |
(174,120 |
) |
Net loss per share attributable to common stockholders,
basic and diluted |
|
$ |
(0.20 |
) |
|
$ |
(0.92 |
) |
|
$ |
(0.51 |
) |
|
$ |
(3.38 |
) |
Weighted-average common shares outstanding, basic and diluted |
|
|
257,283,961 |
|
|
|
68,499,106 |
|
|
|
250,115,414 |
|
|
|
51,492,988 |
|
Net loss |
|
$ |
(50,932 |
) |
|
$ |
(64,596 |
) |
|
$ |
(128,873 |
) |
|
$ |
(178,040 |
) |
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain on available-for-sale investments |
|
|
0 |
|
|
|
(135 |
) |
|
|
(85 |
) |
|
|
(415 |
) |
Foreign currency translation |
|
|
(2,377 |
) |
|
|
37 |
|
|
|
(2,449 |
) |
|
|
215 |
|
Comprehensive loss |
|
|
(53,309 |
) |
|
|
(64,694 |
) |
|
|
(131,407 |
) |
|
|
(178,240 |
) |
Less: Comprehensive loss attributable to
non-controlling interest |
|
|
562 |
|
|
|
(1,515 |
) |
|
|
(332 |
) |
|
|
(3,920 |
) |
Comprehensive loss attributable to American Well Corporation |
|
$ |
(53,871 |
) |
|
$ |
(63,179 |
) |
|
$ |
(131,075 |
) |
|
$ |
(174,320 |
) |
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
AMERICAN WELL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
(in thousands, except share amounts)
(unaudited)
|
|
Common Stock |
|
|
Treasury |
|
|
Additional
Paid-In |
|
|
Accumulated
Other
Comprehensive |
|
|
Accumulated |
|
|
American Well
Corporation
Stockholders’ |
|
|
Noncontrolling |
|
|
Total
Stockholders’ |
|
|
|
Shares |
|
|
Amount |
|
|
Stock |
|
|
Capital |
|
|
Income (Loss) |
|
|
Deficit |
|
|
Equity |
|
|
Interest |
|
|
Equity |
|
Balances as of January 1, 2021 |
|
|
235,604,105 |
|
|
$ |
2,357 |
|
|
$ |
(37,568 |
) |
|
$ |
1,841,405 |
|
|
$ |
297 |
|
|
$ |
(582,359 |
) |
|
$ |
1,224,132 |
|
|
$ |
22,065 |
|
|
$ |
1,246,197 |
|
Exercise of common stock options |
|
|
3,474,375 |
|
|
|
34 |
|
|
|
— |
|
|
|
10,096 |
|
|
|
— |
|
|
|
— |
|
|
|
10,130 |
|
|
|
— |
|
|
|
10,130 |
|
Vesting of restricted stock units |
|
|
853,842 |
|
|
|
9 |
|
|
|
— |
|
|
|
(9 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Retirement of treasury stock purchased in 2020 |
|
|
— |
|
|
|
— |
|
|
|
37,568 |
|
|
|
(15 |
) |
|
|
— |
|
|
|
(37,553 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Shares withheld related to net share settlement and retired treasury stock in 2021 |
|
|
(402,060 |
) |
|
|
(4 |
) |
|
|
— |
|
|
|
4 |
|
|
|
— |
|
|
|
(9,771 |
) |
|
|
(9,771 |
) |
|
|
— |
|
|
|
(9,771 |
) |
Stock-based compensation expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
8,642 |
|
|
|
— |
|
|
|
— |
|
|
|
8,642 |
|
|
|
— |
|
|
|
8,642 |
|
Currency translation adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(52 |
) |
|
|
— |
|
|
|
(52 |
) |
|
|
— |
|
|
|
(52 |
) |
Unrealized gains on available-for-sale
securities, net of tax |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
34 |
|
|
|
— |
|
|
|
34 |
|
|
|
— |
|
|
|
34 |
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(39,188 |
) |
|
|
(39,188 |
) |
|
|
(617 |
) |
|
|
(39,805 |
) |
Balances as of March 31, 2021 |
|
|
239,530,262 |
|
|
|
2,396 |
|
|
|
— |
|
|
|
1,860,123 |
|
|
|
279 |
|
|
|
(668,871 |
) |
|
|
1,193,927 |
|
|
|
21,448 |
|
|
|
1,215,375 |
|
Exercise of common stock options |
|
|
1,812,491 |
|
|
|
18 |
|
|
|
— |
|
|
|
6,656 |
|
|
|
— |
|
|
|
— |
|
|
|
6,674 |
|
|
|
— |
|
|
|
6,674 |
|
Vesting of restricted stock units |
|
|
844,900 |
|
|
|
9 |
|
|
|
— |
|
|
|
(9 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Shares withheld related to net share settlement and retired treasury stock in 2021 |
|
|
(68,750 |
) |
|
|
(1 |
) |
|
|
— |
|
|
|
1 |
|
|
|
— |
|
|
|
(1,857 |
) |
|
|
(1,857 |
) |
|
|
— |
|
|
|
(1,857 |
) |
Stock-based compensation expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10,726 |
|
|
|
— |
|
|
|
— |
|
|
|
10,726 |
|
|
|
— |
|
|
|
10,726 |
|
Currency translation adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(20 |
) |
|
|
— |
|
|
|
(20 |
) |
|
|
— |
|
|
|
(20 |
) |
Unrealized gains on available-for-sale
securities, net of tax |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(119 |
) |
|
|
— |
|
|
|
(119 |
) |
|
|
— |
|
|
|
(119 |
) |
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(37,859 |
) |
|
|
(37,859 |
) |
|
|
(277 |
) |
|
|
(38,136 |
) |
Balances as of June 30, 2021 |
|
|
242,118,903 |
|
|
|
2,422 |
|
|
|
— |
|
|
|
1,877,497 |
|
|
|
140 |
|
|
|
(708,587 |
) |
|
|
1,171,472 |
|
|
|
21,171 |
|
|
|
1,192,643 |
|
Exercise of common stock options |
|
|
491,598 |
|
|
|
5 |
|
|
|
— |
|
|
|
1,872 |
|
|
|
— |
|
|
|
— |
|
|
|
1,877 |
|
|
|
— |
|
|
|
1,877 |
|
Vesting of restricted stock units |
|
|
3,989,239 |
|
|
|
40 |
|
|
|
— |
|
|
|
(40 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Shares withheld related to net share settlement and retired treasury stock in 2021 |
|
|
(211,494 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
(2,360 |
) |
|
|
(2,360 |
) |
|
|
— |
|
|
|
(2,360 |
) |
Issuance of stock under employee stock purchase plan |
|
|
178,021 |
|
|
|
2 |
|
|
|
— |
|
|
|
1,597 |
|
|
|
— |
|
|
|
— |
|
|
|
1,599 |
|
|
|
— |
|
|
|
1,599 |
|
Issuance of common stock in acquisitions |
|
|
12,798,992 |
|
|
|
128 |
|
|
|
— |
|
|
|
143,979 |
|
|
|
— |
|
|
|
— |
|
|
|
144,107 |
|
|
|